Your right about the old west oil holders(directors), it has been happening for a while now, Im pretty sure any of them dont hold a position on the board now, which i think is a good thing as they would know little about the biotech sector.
Not sure the stock is being manipulated, it has a small amount of shares on issue, and did have some great results in the past 12 months, and i feel has been under valued for quite some time.
The issue about its technology being banned in Europe isnt such a big concern, from what i read their main concerns are Australia, the USA and South Africa.
The hardest thing to figure out with Biotechs in the trial stages is their worth, so far Stirlings results have been very good, but how close are they to getting approval and when does the money start flowing in?
Cheers :-)
STI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
